Barricaid logo

Barricaid

Challenger

Barricaid (by Intrinsic Therapeutics) is an FDA-approved bone-anchored annular closure device implanted in 12,000+ patients; CMS raised its ASC reimbursement 46% in 2025; first awake-surgery and endoscopic implantations achieved in 2025.

Best for: Spinal Medical Devices
52
AI Score
Grade C
AI Visibility Score (Beta)
HealthcareSpinal Medical DevicesWebsiteUpdated October 2026

Company Overview

About Barricaid

Barricaid is the commercial brand name for the Barricaid Annular Closure Device (ACD), a medical device developed and marketed by Intrinsic Therapeutics, a clinical-stage medical device company. The Barricaid ACD received FDA premarket approval on February 8, 2019. It is designed to treat lumbar disc herniation by sealing tears in the annulus fibrosus — the tough outer layer of spinal discs — following discectomy (the surgical removal of herniated disc material). By closing the annular defect, Barricaid aims to contain remaining disc material, reduce the likelihood of reherniation, and alleviate nerve compression and back pain.

Business Model & Competitive Advantage

The Barricaid device has been implanted in more than 12,000 patients globally and is supported by extensive clinical evidence across 8 distinct patient populations, including two randomized controlled trials and six single-arm studies. In 2025, the Centers for Medicare & Medicaid Services (CMS) significantly improved Barricaid's reimbursement: the ASC payment rate increased 46% from $6,500 to $9,527, substantially improving the economics for outpatient surgical centers. ISASS (International Society for the Advancement of Spine Surgery) also issued updated 2025 recommendations affirming Barricaid's medical necessity for high-risk discectomy patients with large annular defects.

Competitive Landscape 2025–2026

2025 was a landmark year for Barricaid's clinical advancement: the device was successfully implanted for the first time via an endoscopic (minimally invasive) approach, and separately implanted for the first time in patients under awake sedation (without general anesthesia). These minimally invasive technique expansions are expected to broaden the treatable patient population and increase adoption at outpatient surgery centers. Barricaid competes with Xclose and Inclose as the primary annular closure devices on the market, with Barricaid holding the strongest clinical evidence base.

Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Barricaid is an established challenger with significant market presence and competitive offerings in Healthcare.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

52
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Epic Systems logo

Epic Systems

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Compare Barricaid with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Barricaid

Claim This Profile

Are you from Barricaid? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Barricaid Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Barricaid vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →